Capital markets

Managing partner Martha Notaras, late of XL, discusses the new entrant’s outlook on the sector.

Infusion comes a year after $43 million Series B.

While there's still slightly less action in this space, big bets are on the rise

A look at who broke through in P&C insurance during a big year for insurtech.

Lifted by a $1.5 billion third quarter, this year has already surpassed all of last year for startup cash, says Willis Towers Watson.

A look at an active summer for U.S.-based insurtech investment.

While the number of deals in total is falling, those that are inked are for more total dollars, says Hampleton Partners.

While no nine-digit rounds were recorded in this quarter, investment activity is going strong.

Lemonade banked $300 million in the quarter, far outpacing the field.

The goal is to bring more engineers with experience in autonomous vehicle technology to the iPhone maker.